Catalyst Pharmaceuticals Says District Court Delays Bench Trial To May 18, 2026; Bench Trial Concerns Validity Of FIRDAPSE Patents Expiring In 2032, 2034, 2037

Benzinga Newsdesk www.benzinga.com Neutral 92.5%

Neg 0% Neu 92.5% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001369568/000119312526114306/d111324d8k.htm

Comments

No comments yet. Be the first!